Inventor · disambiguated record
Stewart D. Lyman
Also filed as: LYMAN STEWART · LYMAN STEWART D
28 granted patents·15 pending applications·715 citations·filing 1994–2020
97Inventor score
Top patents by PatentIndex Score
43 records- 0198US5728813AAntibodies directed against elk ligandIMMUNEX CORP·Filed 1996·Granted Mar 17, 1998·165 cites·4 claims
- 0297US5843423AMethods of stimulating hematopoietic cells with flt3-ligandIMMUNEX CORP·Filed 1997·Granted Dec 1, 1998·95 cites·17 claims
- 0394US7786271B2Antibodies that inhibit TSLP activityIMMUNEX CORP·Filed 2008·Granted Aug 31, 2010·23 cites·18 claims
- 0494US6555520B2Human TSLP DNA and polypeptidesIMMUNEX CORP·Filed 2001·Granted Apr 29, 2003·53 cites·14 claims
- 0593US7304144B2Antibodies binding to human TSLP PolypeptidesIMMUNEX CORP·Filed 2003·Granted Dec 4, 2007·38 cites·5 claims
- 0690US7405058B2Human TSLP polynucleotidesIMMUNEX CORP·Filed 2006·Granted Jul 29, 2008·10 cites·13 claims
- 0790US7045128B2Antibodies against flt3-ligandIMMUNEX CORP·Filed 2002·Granted May 16, 2006·20 cites·15 claims
- 0890US5554512ALigands for flt3 receptorsIMMUNEX CORP·Filed 1994·Granted Sep 10, 1996·89 cites·21 claims
- 0987US5670625AElk ligand fusion proteinsIMMUNEX CORP·Filed 1995·Granted Sep 23, 1997·35 cites·12 claims
- 1085US7709217B2Modified human thymic stromal lymphopoietinIMMUNEX CORP·Filed 2007·Granted May 4, 2010·3 cites·5 claims
- 1185US5512457ACytokine designated elk ligandIMMUNEX CORP·Filed 1994·Granted Apr 30, 1996·48 cites·13 claims
- 1284US7973151B2Nucleic acid encoding modified human thymic stromal lymphopoietinIMMUNEX CORP·Filed 2010·Granted Jul 5, 2011·4 cites·19 claims
- 1381US6190655B1Methods of using Flt-3 ligand for exogenous gene transferIMMUNEX CORP·Filed 1998·Granted Feb 20, 2001·36 cites·24 claims
- 1481US5627267ACytokine designated elk ligandIMMUNEX CORP·Filed 1995·Granted May 6, 1997·23 cites·10 claims
- 1580US9045558B2Nucleic acids encoding modified human thymic stromal lymphopoietinIMMUNEX CORP·Filed 2013·Granted Jun 2, 2015·2 cites·18 claims
- 1680US8598318B2Modified human thymic stromal lymphopoietinLYMAN STEWART D·Filed 2012·Granted Dec 3, 2013·4 cites·12 claims
- 1779US8444979B2Antibodies that inhibit TSLP activitySIMS JOHN E·Filed 2011·Granted May 21, 2013·3 cites·9 claims
- 1878US6630143B1Antibodies against flt3 ligandIMMUNEX CORP·Filed 1996·Granted Oct 7, 2003·31 cites·15 claims
- 1977US9346870B2Antibodies that inhibit TSLP activityIMMUNEX CORP·Filed 2014·Granted May 24, 2016·2 cites·12 claims
- 2075US2021102955A1Methods to Determine the Presence of an Antibody that Binds Modified Human Thymic Stromal Lymphopoietin (TSLP)AMGEN INC·Filed 2020·Application pending·0 cites
- 2170US7288633B2Modified human thymic stromal lymphopoietinIMMUNEX CORP·Filed 2002·Granted Oct 30, 2007·2 cites·7 claims
- 2268US2009075886A1Dendritic cell stimulatory factorIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 2366US7329740B2Flk-1 binding proteinIMMUNEX CORP·Filed 2005·Granted Feb 12, 2008·0 cites·3 claims
- 2466US2016377630A1Methods to determine the presence of an antibody that binds modified human thymic stromal lymphopoietin (tslp)IMMUNEX CORP·Filed 2016·Application pending·0 cites
- 2566US2011053863A1Methods of using flt3-ligand in the treatment of cancerCELLDEX THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2666US2007207164A1Methods of using flt3-ligand in the treatment of cancerIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 2765US6632424B1Human FLTS3 ligandIMMUNEX CORP·Filed 1995·Granted Oct 14, 2003·19 cites·22 claims
- 2865US2004022767A1Novel cytokine designated elk ligandFiled 2003·Application pending·0 cites
- 2962US2013225490A1Antibodies That Inhibit TSLP ActivitySIMS JOHN ERNEST·Filed 2013·Application pending·0 cites
- 3062US2011230637A1Modified human thymic stromal lymphopoietinIMMUNEX CORP·Filed 2011·Application pending·0 cites
- 3161US2004037845A1Use of flt3-ligand in the treatment of infectionFiled 2003·Application pending·0 cites
- 3259US2015252089A1Modified Human Thymic Stromal LymphopoietinIMMUNEX CORP·Filed 2015·Application pending·0 cites
- 3358US7041282B2Ligands for flt3 receptorsIMMUNEX CORP·Filed 2001·Granted May 9, 2006·0 cites·10 claims
- 3458US2008188643A1flk-1 binding proteinIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 3557US7294331B2Methods of using flt3-ligand in hematopoietic cell transplantationIMMUNEX CORP·Filed 2002·Granted Nov 13, 2007·1 cites·60 claims
- 3657US6762030B2Ligand for CD7 and methods for use thereofIMMUNEX CORP·Filed 2001·Granted Jul 13, 2004·1 cites·14 claims
- 3756US2010266601A1Antibodies that inhibit tslp activityIMMUNEX CORP·Filed 2010·Application pending·0 cites
- 3854US6994989B1FLK-1 binding proteinsIMMUNEX CORP·Filed 1996·Granted Feb 7, 2006·7 cites·9 claims
- 3951US2005058622A1Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimensFiled 2003·Application pending·0 cites
- 4041US2004131587A1Method for treatment of tumors using combination therapyFiled 2003·Application pending·0 cites
- 4137US6919206B2Medium containing flt3 ligand for culturing hematophoietic cellsIMMUNEX CORP·Filed 1997·Granted Jul 19, 2005·1 cites·16 claims
- 4232US6540992B1Methods for using elk-L to enhance neuronal survivalGENENTECH INC·Filed 1998·Granted Apr 1, 2003·0 cites·7 claims
- 4329US2002034517A1Dendritic cell stimulatory factorFiled 1999·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →